EmpleoRelaciones con InversoresComunicados de PrensaCOVID-19
  1. Siemens Healthineers Chile
  2. Point-of-Care Testing
  3. Webinars
  4. The connection between Covid-19 and Diabetes: Where are we headed?

The connection between Covid-19 and Diabetes: Where are we headed?

Now on Demand

 

1 hour

|2022-11-04

Overview

The post infection consequences of Covid-19 are only starting to be fully realized. Initially, studies indicated that patients with diabetes had a higher chance of serious complications from Covid-19. However, recent reports now suggest an increased risk of diabetes diagnosis after a Covid-19 infection. During this discussion of diabetes in the context of Covid-19, Dr. Kaufman explains why HbA1c testing is even more important in today’s healthcare landscape and explores the hypotheses and pathophysiology behind this recent trend.

Who Should Attend?

Point-of-care coordinators, nurses, diabetologists, physicians, endocrinologists, clinicians, patients, providers, and researchers


Attendees are entitled to P.A.C.E. credits from the ASCLS and/or ACCENT credits from the AACC 

Francine Kaufman

Francine Kaufman, M.D. 

Speaker Information

Dr. Kaufman is a Distinguished Professor Emerita of Pediatrics and Communications at the Keck School of Medicine of the University of Southern California, the Center for Endocrinology, Diabetes, & Metabolism at the Children’s Hospital in Los Angeles. She also serves as the Chief Medical Officer at Senseonics, Inc., the creators of the first and only long-term implantable CGM.

Learning Objectives

  • Understand of the pathophysiology of diabetes 
  • How an infection or inflammation interacts with patients with diabetes 
  • Learn how Covid-19 altered diabetes assessment and management